<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">38657151</PMID><DateCompleted><Year>2024</Year><Month>04</Month><Day>24</Day></DateCompleted><DateRevised><Year>2024</Year><Month>04</Month><Day>24</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">2306-4102</ISSN><JournalIssue CitedMedium="Print"><Volume>38</Volume><Issue>1</Issue><PubDate><Year>2024</Year><Season>Jan-Feb</Season></PubDate></JournalIssue><Title>Acta ortopedica mexicana</Title><ISOAbbreviation>Acta Ortop Mex</ISOAbbreviation></Journal><ArticleTitle>[Avascular necrosis of the hip secondary to long-standing COVID].</ArticleTitle><Pagination><StartPage>48</StartPage><EndPage>51</EndPage><MedlinePgn>48-51</MedlinePgn></Pagination><Abstract><AbstractText>Long COVID is a term used to describe the long-terms effects of COVID-19 infection that continue for weeks or months after the patient has recovered from COVID-19. Long COVID is defined by the persistence of symptoms beyond 12 weeks from the onset of the disease. Corticosteroids are part of the treatment in this period with good results in controlling the disease; however, it is a predisposing factor for the development of avascular necrosis. We present a clinic case of a young man of 39 years old with diagnosis of avascular necrosis in his left hip, before the administration of corticosteroids for the treatment of COVID-19. There is a lack of consensus about the dosage and duration of steroids required to develop avascular necrosis. Some authors have reported that cumulative dose of 2,000 mg prednisone (or its equivalent) was required for avascular necrosis development. For patients with advanced avascular necrosis stages total hip arthroplasty is an attractive option with excellent outcomes in terms of pain relief and survivorship.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Garc&#xed;a-Dobarganes-Barlow</LastName><ForeName>F E</ForeName><Initials>FE</Initials><AffiliationInfo><Affiliation>Hospital &#xc1;ngeles Quer&#xe9;taro. M&#xe9;xico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Valadez-Soto</LastName><ForeName>J M</ForeName><Initials>JM</Initials><AffiliationInfo><Affiliation>Hospital &#xc1;ngeles Quer&#xe9;taro. M&#xe9;xico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Saavedra-Islas</LastName><ForeName>N</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Hospital &#xc1;ngeles Quer&#xe9;taro. M&#xe9;xico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Garc&#xed;a-Romo</LastName><ForeName>V M</ForeName><Initials>VM</Initials><AffiliationInfo><Affiliation>Hospital &#xc1;ngeles Quer&#xe9;taro. M&#xe9;xico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mata-Coronado</LastName><ForeName>J</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Hospital &#xc1;ngeles Quer&#xe9;taro. M&#xe9;xico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Villavicencio-Ocampo</LastName><ForeName>E</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Hospital &#xc1;ngeles Quer&#xe9;taro. M&#xe9;xico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Encalada-D&#xed;az</LastName><ForeName>M I</ForeName><Initials>MI</Initials><AffiliationInfo><Affiliation>Hospital M&#xe9;dica Sur. M&#xe9;xico.</Affiliation></AffiliationInfo></Author></AuthorList><Language>spa</Language><PublicationTypeList><PublicationType UI="D002363">Case Reports</PublicationType><PublicationType UI="D004740">English Abstract</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><VernacularTitle>Necrosis avascular de cadera secundaria a COVID de larga duraci&#xf3;n.</VernacularTitle></Article><MedlineJournalInfo><Country>Mexico</Country><MedlineTA>Acta Ortop Mex</MedlineTA><NlmUniqueID>101190312</NlmUniqueID><ISSNLinking>2306-4102</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D005938">Glucocorticoids</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005271" MajorTopicYN="Y">Femur Head Necrosis</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019644" MajorTopicYN="N">Arthroplasty, Replacement, Hip</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005938" MajorTopicYN="N">Glucocorticoids</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName></MeshHeading></MeshHeadingList><OtherAbstract Type="Publisher" Language="spa"><AbstractText>El COVID de larga duraci&#xf3;n es un t&#xe9;rmino que describe la enfermedad en pacientes que se recuperaron de una infecci&#xf3;n por COVID-19 y reportan s&#xed;ntomas por m&#xe1;s de 12 semanas. Los corticosteroides forman parte del tratamiento en este per&#xed;odo con buenos resultados en el control de la enfermedad; sin embargo, el uso de este grupo de medicamentos se ha descrito como un factor de riesgo para el desarrollo de necrosis avascular. Se describe el caso cl&#xed;nico de un paciente masculino de 39 a&#xf1;os con diagn&#xf3;stico de necrosis avascular de la cadera izquierda posterior a la administraci&#xf3;n de corticosteroides para el tratamiento de COVID-19. La dosis de esteroides capaz de provocar necrosis avascular no est&#xe1; clara o bien descrita; sin embargo, existen reportes en la literatura donde se habla de dosis de 2,000 mg de prednisona (o equivalentes) para su desarrollo. El tratamiento de la necrosis avascular tiene como objetivo el alivio del dolor, retardar la progresi&#xf3;n del cuadro, prevenir el colapso en etapas tempranas y restaurar la funci&#xf3;n articular. La artroplast&#xed;a o recambio total de cadera parece ser una excelente opci&#xf3;n de tratamiento quir&#xfa;rgico para aquellos pacientes en etapas avanzadas.</AbstractText></OtherAbstract><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">avascular necrosis</Keyword><Keyword MajorTopicYN="N">corticosteroids</Keyword><Keyword MajorTopicYN="N">total hip arthroplasty</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>4</Month><Day>24</Day><Hour>19</Hour><Minute>7</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>4</Month><Day>24</Day><Hour>19</Hour><Minute>6</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>4</Month><Day>24</Day><Hour>15</Hour><Minute>23</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38657151</ArticleId><ArticleId IdType="pii">S2306-4102(24)114665-0</ArticleId></ArticleIdList></PubmedData></PubmedArticle></PubmedArticleSet>